Kansas Governor Bans 7-OH Kratom Related Substances, Raising Stakes for Industry Compliance

Kansas Governor Bans 7-OH Kratom Related Substances, Raising Stakes for Industry Compliance

TOPEKA, KS – Kansas has enacted a significant restriction on kratom, with Governor Laura Kelly signing House Bill 2365 into law on April 10, 2026. The new legislation designates "7-OH kratom related substances" as Schedule I controlled substances, placing them in the same category as drugs with a high potential for abuse and no accepted medical use. Governor Kelly emphasized the need to "safeguard the health of Kansans" while the U.S. Food and Drug Administration (FDA) continues its evaluation of kratom's safety and efficacy.

This legislative action marks a pivotal moment for kratom consumers and businesses in Kansas. For consumers, it means that products containing these specific 7-OH kratom related substances are now illegal to possess or purchase within the state. For kratom merchants operating in Kansas, the law demands an immediate cessation of sales and distribution of any such prohibited compounds to avoid severe legal repercussions. The ban underscores the ongoing, fragmented regulatory landscape confronting the kratom industry across the United States. While advocates for the Kratom Consumer Protection Act (KCPA) often highlight the distinction between natural kratom leaf and high-potency synthetic derivatives, Kansas has opted for a prohibitory approach concerning 7-OH related substances, adding another layer of complexity for businesses operating nationally.

The compliance implications are immediate and critical. Businesses must ensure absolute certainty regarding the chemical composition of their kratom products, particularly those distributed in or shipped to Kansas. Any product found to contain "7-OH kratom related substances" is now illegal in the state, making robust internal compliance protocols and transparent supply chains non-negotiable.

For high-risk merchants, comprehensive Certificates of Analysis (COAs) and independent third-party lab testing are no longer merely best practices but essential legal safeguards. These documents must unequivocally identify the presence and quantity of all major alkaloids, especially 7-hydroxymitragynine (7-OH), to demonstrate adherence to state laws like Kansas's new ban. It is paramount that merchants verify their products, particularly extracts or enhanced formulations, do not inadvertently contain concentrations of 7-OH that could fall under the new Schedule I designation. Regular and transparent lab testing is crucial for mitigating the significant legal and financial risks associated with non-compliance, including product seizures, hefty fines, and potential criminal charges. Staying informed about the constantly evolving state and local regulations remains paramount, as the legal status of kratom and its various derivatives continues to be highly dynamic across the nation.